Related Experiment Video
Updated: Sep 20, 2025

05:27
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
1.7K
MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Fangnan Zhao1,2, Yuling Liu1,2, Fangshun Tan1,2
1Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, China.
Current Pharmaceutical Design
|June 8, 2022
Summary
Long non-coding RNA MIR4435-2HG acts as an oncogene across numerous cancers, influencing tumor progression and patient prognosis. This review clarifies its role in various tumor types and potential as a diagnostic and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (LncRNAs) significantly impact tumor progression, driving extensive research.
- Several LncRNAs are implicated in promoting tumor growth, migration, and invasion across various cancers.
Purpose of the Study:
- To elucidate the pathophysiological functions of LncRNA MIR4435-2HG in multiple tumor types.
- To summarize the relationship between MIR4435-2HG and cancer development and its molecular mechanisms.
Main Methods:
- Literature search conducted through PubMed.
- Synthesis of existing research on MIR4435-2HG's role in cancer.
Main Results:
- MIR4435-2HG functions as an oncogene, with elevated expression observed in melanoma, gastric, lung, breast, and other cancers.
- High MIR4435-2HG levels correlate with poor prognosis and affect tumor proliferation, invasion, and apoptosis.
- MIR4435-2HG also influences the metabolic function of myeloid dendritic cells in HIV-1 controllers.
Conclusions:
- MIR4435-2HG plays a critical role in the development of diverse cancers.
- MIR4435-2HG shows potential as a clinical biomarker for early tumor detection and a target for cancer therapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K

